Aktis Oncology Announces $175 Million Series B Financing
ISCT Achieves ANAB Accreditation for Excellence in Cell and Gene Therapy Workforce Development
Precision Diagnostics with AI and Cardiogenomics for Heart Conditions
Naveris Showcases Groundbreaking Data on NavDx® Test for HPV-Driven Cancers at ASTRO 2024
Sinai Health Receives $1-Million Donation to Revolutionize Cancer Diagnostics with Digital Pathology Integration
Nanostics and OncoHelix Partner to Launch AI-Driven Prostate Cancer Test in the Middle East
QIAGEN Secures European IVDR Certification for QIAstat-Dx Syndromic Testing Systems and Assays
Bayer and AskBio Partner with Belief BioMed to Develop Liver-Targeted Gene Therapies
Breakthrough Stem Cell Transplant Offers Insulin Independence for Type 1 Diabetes Patient
Tagrisso Gains FDA Approval for Treatment of Unresectable Stage III EGFR-Mutated Lung Cancer in the US
Tempus and Takeda Expand Partnership to Enhance Cancer Drug Development with Real-World Data
MedGenome and Twist Bioscience Partner to Launch HOPE for Rare Diseases Programme in India
Bioserve Biotechnologies Unveils PreciOnc: Revolutionizing At-Home Genetic Testing for Cancer Risk
Trinity Biotech Expands Maternal Health Portfolio with Acquisition of Metabolomics Diagnostics
Cepheid and Fleming Initiative Join Forces to Combat Antimicrobial Resistance